Bausch Health Companies | VRX - Equity Capital And Reserves

Stock Price
7.84
Daily Change
0.07 0.90%
Monthly
-25.83%
Yearly
-16.33%
Q1 Forecast
7.62

Bausch Health Companies reported $356M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Amgen USD 9.62B 2.19B Sep/2025
ANI Pharmaceuticals USD 505.82M 69.06M Sep/2025
Aurora Cannabis CAD 567.1M 21.58M Sep/2025
Bausch Health Companies USD 356M 209M Sep/2025
Biogen USD 18.21B 573.5M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Canopy Growth CAD 736.01M 247.04M Sep/2025
Corcept Therapeutics USD 631.9M 3.89M Sep/2025
Danaher USD 52.53B 1.46B Dec/2025
Drreddys Laboratories INR 4.14B 107.72M Dec/2025
Eli Lilly USD 23.79B 5.52B Sep/2025
Gilead Sciences USD 21.46B 1.78B Sep/2025
Novo Nordisk DKK 194.05B 24.15B Dec/2025
Pacira USD 727.21M 30.55M Sep/2025
Perrigo USD 4.45B 25.8M Sep/2025
Prestige Brands USD 1.83B 4.48M Dec/2025
Supernus Pharmaceuticals USD 1.05B 14.23M Sep/2025
Vertex Pharmaceuticals USD 17.32B 143.4M Sep/2025
Zoetis USD 5.4B 421M Sep/2025